Bio-tech brightening

November 2, 2012 – 10:01 AM

Empire Genomics has been grinding it out as a bio-tech start-up in Buffalo for six years. Built on the brains of founder and chief science officer Norma Jean Nowak, the company just released its first genomic test to help determine a personalized treatment for multiple myeloma, a cancer of the blood.

That’s fantastic news for people suffering with the disease, and great news for Buffalo’s bio-tech industry. As we all learned last month when SmartPill, another local start-up, was sold to a firm from Israel, it’s a long and expensive road to launch a successful bio-tech company.

Genomics says it will hire 50 people in the next five years. The company has made bold predictions before. This time it may be able to deliver.


You can leave a response, or trackback from your own site.

Leave a Reply